Related Experiment Video
Updated: Mar 21, 2026
11:13
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
40.3K
The Challenge of Clostridium difficile Infection.
David C Olson1, Martin W Scobey2
1gastroenterology fellow, Gastroenterology Section, Department of Internal Medicine, Carolinas Medical Center, Charlotte, North Carolina.
North Carolina Medical Journal
|May 8, 2016
Summary
Clostridium difficile infection (CDI) poses a significant threat in the US, causing severe illness, death, and high healthcare costs. This review updates on CDI epidemiology, diagnosis, management, and persistent challenges.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Clostridium difficile infection (CDI) is a major healthcare concern in the United States.
- CDI leads to substantial patient morbidity, mortality, and significant financial burdens on the healthcare system.
Purpose of the Study:
- To provide an updated overview of Clostridium difficile infection.
- To cover key aspects including epidemiology, diagnosis, and current management strategies.
- To highlight the ongoing challenges associated with CDI.
Main Methods:
- This commentary synthesizes current literature and clinical guidelines.
- It reviews epidemiological data, diagnostic approaches, and therapeutic recommendations.
- Expert opinion and clinical experience inform the discussion of challenges.
Main Results:
- CDI remains a critical issue with evolving epidemiology.
- Accurate and timely diagnosis is crucial for effective management.
- Current management involves antibiotics, but challenges like recurrence and resistance persist.
Conclusions:
- Effective control of CDI requires a multi-faceted approach.
- Continued research and updated clinical practices are essential to combat CDI.
- Addressing the challenges in diagnosis and management is vital to reduce morbidity, mortality, and costs.
Related Concept Videos
01:12Bacterial Toxins
2
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
2
01:25Clinical Significance of Antibiotic Resistance
10
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
10
01:17Urinary Tract Infection IV: Nursing Management
580
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
580
01:24Cystic Fibrosis: Management
612
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
612
01:17Chronic Bowel Disorders: Introduction
895
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
895
01:17Drugs for Treatment of Diarrhea-Predominant IBS
854
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
854